[ad_1]
Startup Monod Bio Inc. has secured $25 million in seed financing to develop a new technology designed to speed disease detection and help physicians manage patients with chronic conditions.
Seattle-based Monod is developing an instrument that could be used for diagnostic applications at the point of care. Monod hasn’t revealed its initial…
.
|
Sources 2/ https://www.wsj.com/articles/biotech-startup-monod-bio-collects-25-million-seed-financing-11660557600 The mention sources can contact us to remove/changing this article |
[ad_2]